Customized Screening for Opioid Use Disorder and Chronic Pain (OPTIC Trial)

N/A

Recruiting

Led By Matthew R Pearson, PhD

Research Sponsored by University of New Mexico

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Report current chronic pain and/or opioid misuse/opioid use disorder

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months (or duration of implementation phase)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study how to customize screening and brief intervention for chronic pain and opioid misuse in American Indian and Alaska Native clinics. It will also look at staff views on this process and gather information from

Who is the study for?

The OPTIC trial is for individuals in American Indian and Alaska Native communities who are dealing with chronic pain and opioid misuse or disorder. It's focused on improving screening and intervention methods that are culturally tailored to these communities.

What is being tested?

This study tests the process of implementing strategies specifically designed for AI/AN clinics to better address chronic pain and opioid misuse. It includes gathering feedback from clinic staff as well as surveying patients affected by these issues.

What are the potential side effects?

Since this trial focuses on implementation strategies rather than medications, there aren't direct side effects like those associated with drug trials. However, participants may experience emotional or psychological impacts during the screening and intervention processes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently experiencing chronic pain or have a history of opioid misuse.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months (or duration of implementation phase)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months (or duration of implementation phase)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months (or duration of implementation phase) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of clients screened for chronic pain and opioid misuse/opioid use disorder

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Active Control

Group I: SustainmentActive Control1 Intervention

Measuring the degree to which the clinic maintains the implementation phase goals.

Group II: ImplementationActive Control1 Intervention

Evidence-based implementation strategies are put into practice for approximately 6 months.

Group III: Pre-InterventionActive Control1 Intervention

Baseline prior to any involvement with the project

Group IV: InterventionActive Control1 Intervention

A workgroup for each clinic meets for approximately 6 months to select the specific goals for the clinic to be targeted during the implementation phase.

0 / 1Eligibility criteria met